serum estradiol (E 2 ), and low pregnancy rates (2). This oral contraceptives, whereas there seems to be no benefit phenomenon was first described by Garcia et al. (3) from cotreatment with growth hormone or glucocorticoids.
a low peak E 2 level [upper limit at 500 pg/ml or even multicenter study of IVF (11) showed that the probability of success of ART decreased progressively after 1000 pg/ml on the day of human chorionic gonadotropin (hCG) administration] in a previous stimulation the age of 30 years and declined markedly after the age of 35 years. A similar decreasing trend in the cycle could be characterized as low responders (4) . Also, some designate maternal age Ն 40 years as a residual follicle count within both ovaries has been demonstrated, as ovarian follicle atresia is accelerated salient factor in the low response category (5) . Low response to COH frequently reflects an age-related after the age of 38 years (12). In accordance to these, Lass et al. (13) , who recently evaluated 1087 IVF decline in reproductive performance, but the same phenomenon may occur in young patients (6) . Some cycles initiated in 471 women Ն 40 years of age, reported that the pregnancy rate was significantly women have an occult ovarian failure, evidenced by a basal or clomiphene-induced increase in serum follilower in these women than in a control group of women Ͻ 40 years of age (11.3% vs. 28.2%, respectively). cle-stimulating hormone (FSH) levels, whereas others have normal serum FSH and no apparent reason for
The pregnancy rate decreased sharply in women Ͼ 42 years of age, and no women Ͼ 45 achieved a live repeated low responses to aggressive stimulation protocols (7) . Several mechanisms have been proposed to birth (13). However, in the latest Human Fertilization and Embryology Authority Report, a 10.4% live birthexplain low response in these women with normal age and FSH; however, none of these hypotheses has ever rate per treatment cycle was reported for 96 women of Ն 45 years of age undergoing ART treatment (14) . been proved, suggesting that these patients also may have diminished ovarian reserve (8) .
Also, for women Ͼ 39 years of age, a 10.7% and 7.0%, pregnancy and live birthrate per treatment cycle, Since the evolution of ART, the management of these infertile patients has been one of the most diffirespectively, were reported in the 1996 ART Report of the American Society for Reproductive Medicine cult challenges and disappointing issues in reproductive medicine. It is the purpose of this review to (15). Thus, it seems that age alone is not the only outcome-determining factor for patients undergoing summarize the proposed methods of evaluation and currently available treatment strategies of low respondARTs, nor is it a reliable predictor for patients over or under 40 years of age. ers in ART. The possibility of applying micromanipulation techniques in order to overcome oocyte aging will be discussed.
Hormonal Tests of Ovarian Reserve
Several hormone biomarker tests of ovarian reserve PREDICTION OF OVARIAN STIMULATION OUTCOME have been reported (Table I ). The most commonly used is the serum FSH assay on cycle day 3, which has proved to be highly predictive of diminished ovarian Identifying low responders prior to initiation of hormonal treatment for in vitro fertilization-embryo reserve, as defined by poor gonadotropin responsiveness and pregnancy rates in patients undergoing transfer (IVF-ET) is extremely important, so that the patients can be counseled regarding the lower chances ART. Toner et al. (16) reported on a series of 1478 consecutive IVF cycles that basal day 3 FSH levels for pregnancy, have realistic expectations, and consider alternative therapies such as oocyte donation or adopscreening showed that the cancellation rates for patients with levels of Ͻ15 mIU/ml, 20 mIU/ml, 25 tion. In addition, stimulation protocols for these patients can be modified to lower the risk of cancellamIU/ml, and Ͼ 30 mIU/ml were 5%, 10%, 20%, and 40%, respectively. Also, in a retrospective study of tion and improve pregnancy rates. As a result, numerous screening methods have been proposed to assess 758 IVF cycles, Scott et al. (17) found that pregnancy rates decrease markedly as basal day 3 FSH levels prospectively ovarian reserve and to individualize treatment regimens.
increased. Specifically, women with serum FSH Ͻ 15mIU/ml had a pregnancy rate double that of women with levels of 15 to 24.9 mIU/ml and sixfold higher Age than that of women with a concentration of Ն25 mIU/ ml. This reduction in pregnancy rates was attributed Ovarian reserve decline has been clearly related to age; however, the prognostic value of age alone has to decreased ovarian reserve because these patients produced fewer follicles, had fewer oocytes aspirated, not yet been established (9). An earlier cohort study of artificial insemination by donor (10) and a recent and had fewer embryos transferred. In an effort to further characterize the ovarian day 3 FSH and E 2 values might improve the prognostic reserve, other markers of hypothalamic-pituitaryability of either of these hormones used alone. ovarian axis function were examined. In the natural
The variation of basal FSH in different cycles and menopause, FSH and luteinizing hormone (LH) levels the fact that some poor responders have a normal day increase with diminishing ovarian reserve. Lenton et 3 FSH led to the proposal of ovarian performance al. (18) demonstrated that serum FSH increases several predictive tests. Navot et al. (22) proposed the clomiyears before elevations in serum LH, and as a result phene citrate (CC) challenge test as a means of the first intimation of a diminished ovarian reserve assessing ovarian reserve in women Ն 35 years of may be an elevated FSH:LH ratio. Mukherjee et al. age. Simply, serum FSH determinations are obtained (19) applied this finding in women of reproductive on cycle day 3 (basal) and then again on cycle day 10 age undergoing COH for IVF-ET and have shown that (stimulated) after the administration of 100 mg of CC in patients with a normal day 3 FSH an FSH:LH ratio during days 5 to 9. An abnormal test is defined by an Ͼ 3.6 had a sensitivity of 85% and a specificity of elevated value in the day 10 (FSH Ͼ 10 IU/liter) 95% for predicting a poor response to COH.
sample compared with that of day 3. Obviously, an A day 3 serum E 2 determination also has been proabnormal value on cycle day 3 also results in the test posed as a means of assessing reproductive potential being considered abnormal. in women prone to undergo IVF. Studies have shown Several groups evaluated the predictive value of CC that increasing levels of day 3 E 2 are related with challenge test screening in patients participating in a decrease in the number of oocytes retrieved and ART programs. Tanbo et al. (23) studied 91 women pregnancy rates. Specifically Smotrich et al. (20) demover age 35 undergoing IVF and found abnormal CC onstrated that day 3 E 2 levels Ͼ 80 pg/ml in a cycle challenge tests in 37. The predictive value of an abnorproximate but before performing IVF strongly and mal test was 85% for cycle cancellation due to poor independently predicted poor ovarian response and ovarian responsiveness and 100% for failing to conclinical outcome, as these patients had a higher cancelceive. In contrast, cancellation rates were much lower lation rate and achieved a lower pregnancy rate.
(31.5%) and pregnancy rates much higher (11%) in Patients with day 3 E 2 concentration Ն 100 pg/ml those patients with normal tests. Several other studies achieved no pregnancies. It should be noted that their reported similar results, confirming the excellent predata also confirmed the utility of the day 3 FSH levels dictive value of the CC challenge test for diminished as a predictor. Similar results were reported by Licciardi et al. (21) , who proposed that the combination of ovarian reserve and poor long-term pregnancy rates in natural cycles, during ovulation induction, and in IVF correlated positively with oocyte recovery rates, and thus proposed that detection and quantification of fol- (24, 25) .
The Norfolk group proposed the gonadotropinlicular vascularity with color Doppler imaging may be used to predict oocyte recovery rate. Other studies also releasing hormone-agonist (GnRH-a) stimulation test, which evaluates the change in E 2 level from cycle day have reported higher pulsatility and resistance indices in low responders compared to normal controls (31, 2 to 3 after the administration of 1 mg of leuprolide acetate (26) . The group described a strong correlation 32). Chang et al. (33) recently reported a clear correlation between the number of antral (2-5 mm) follicles between the change in E 2 level and several parameters of IVF success and advocated the test for selected under basal conditions and the outcome of ART. A total of 149 treatment cycles for 130 couples were patients undergoing IVF. In particular, patients showing at least a doubling of their baseline E 2 level on performed, and the number of antral follicles with a diameter of 2-5 mm was determined on the first or day 3 compared with that on day 2 achieved a higher number of oocytes retrieved and pregnancy rates. On second day of menstruation or just before the administration of gonadotropins. The number of antral follicles the other hand, in patients who experienced less than a doubling of their E 2 level on day 3 compared with correlated significantly with patient age, day 3 serum FSH level, dosage of menotropin ampules used, serum that on day 2, the cycle cancellation rate was higher, whereas the number of oocytes retrieved and the preg-E 2 concentration, number of oocytes retrieved, and later number of oocytes or embryos transferred. The nancy rates were lower.
Scott et al. (27) in a recent review of the literature group of patients who had a lower antral follicle count (Յ 3) also had a significantly higher rate of cycle proposed that currently the best characterized and most sensitive screening tool available is the CC challenge cancellation compared with the other groups who had a higher antral follicle count. The introduction of threetest. This test may be superior to basal FSH screening; however, further data are needed in order to recomdimensional ultrasonography as a diagnostic instrument in reproductive medicine has added a new dimenmend omission of the day 3 FSH sample, and thus currently the majority of ART programs still continue sion to ultrasound examination of the ovary. Using this approach, the reproducibility of ovarian volume to screen their patients with both day 3 and day 10 FSH levels (27) . measurements has already been proved as well as its efficacy in the diagnosis of ovarian masses (34) . Moreover, it is possible to document follicles measuring Ultrasonographic Evaluation 2-3 mm, as well as the process of follicular selection and dominance (35). Based on these findings, Pellicer Despite the implementation of the above-described hormone tests, the 1993 Annual Report for the Society et al. (36) recently proposed the introduction of threedimensional ultrasonography in the evaluation of ovarfor Assisted Reproductive Technologies (28) documented a cancellation rate of 14% per initiated IVF ian reserve in young low responders with normal basal levels of FSH and showed that low responders exhibcycle. Thus, other means of evaluating ovarian response were investigated.
ited a statistically significant decrease in the total number of follicles and in the number of selectable follicles Recent studies have found a good correlation between ovarian response to stimulation and ultrasonoas compared with normal responders. Data reported at the present time suggest that ultragraphic findings, providing the rationale for wide use of this noninvasive technique. Zaidi et al. (29) investisonography may be a useful noninvasive tool in the prediction of ovarian reserve and ovarian response to gated the relationship between ovarian stromal blood flow to subsequent follicular response and found that stimulating drugs; however, future standardization of the criteria used is necessary in order to achieve its mean ovarian stromal peak systolic blood flow velocity was significantly lower in the low response group and clinical routine application (37). that the odds of a poor response decreased significantly as peak systolic blood flow velocity increased. They proposed that the measurement of ovarian stromal OVULATION INDUCTION PROTOCOLS IN LOW RESPONDERS blood flow before ovarian stimulation might be a new indicator for predicting subsequent ovarian responsiveness (29) . Oyesanya et al. (30) reported that follic-
The ideal approach to patients who respond poorly to traditional controlled ovarian hyperstimulation regiular vascularity index (ratio of the number of follicles with demonstrable pulsatile vascularity to the total) mens remains one of the major challenges in ART.
Several stimulation protocols have been described with out GnRH-a. Cancellation rate, length of stimulation, and peak E 2 levels, did not differ significantly between varying success (Table II) .
the two stimulating regimens, although more ampules of hMG were required in the non-CC cycles to achieve CC-hMG Cycles similar results. However, the implantation rate per embryo and live birthrate per transfer were signifiClomiphene citrate has been widely used in combination with hMG to induce multiple follicular developcantly higher in the CC/hMG cycles than in the previous gonadotropin-stimulated cycles (13.6% and 26.2% ment at the inception of IVF. Its use in ART has been limited following the introduction of GnRH-a/hMG vs. 0.7% and 0%, respectively). These researchers concluded that low-response patients may benefit from protocols, which were found to lead to a greater number of retrieved oocytes, increased pregnancy rates, the addition of CC to their ovarian stimulation protocol, and that this beneficial effect may be related to better scheduling, and lower cancellation rates (38). Clomiphene citrate/hMG regimens still seem to have an enhanced embryo quality as suggested by a higher cleavage rate and a greater implantation rate per an important role in the treatment of low responders. Dor et al. (39), in a retrospective study of 1099 IVF embryo. In a well-controlled study, utilizing CC/hMG in a poor-responder group of 51 patients previously cycles treated with GnRH-a/hMG, hMG, or CC/hMG have shown that GnRH-a-containing protocols procancelled on a high-dose hMG protocol, Pellicer et al. (1) found that certain subgroups (separated according vided significantly lower cancellation rates. However, in women over 40, GnRH-a/hMG resulted in the highto the pattern of the E 2 profile) responded better with this protocol compared to hMG protocols for IVF. est rate of poor ovarian response. Despite more oocytes retrieved, fertilized, and cleaved after the use of GnRHSimilar conclusions were reached by Ben-Rafael et al. (41) who proposed that in elderly poor responders a/hMG, the clinical pregnancy rate was the highest with CC/hMG compared with the other two treat-CC/hMG is cost-effective and should be the first-line attempt. Also, in a retrospective study of 271 patients, ments (39).
Benadiva et al. (50) reported lower pregnancy rates in IVF-ET with high dosages of exogenous responders (10%) were comparable to those achieved by poor responders (11.9%) who had GnRH-a/hMG gonadotropins, suggesting a possible deleterious effect of excess hMG on the ability to establish a pregnancy. using the long protocol. They concluded that for such poor responders, three attempts of IVF in a CC cycle Recently, Land et al. (51), in an attempt to improve the outcome in poor responders, doubled the dose of might offer a viable therapeutic alternative before reverting to more stressful, expensive, and time-conhMG in the second cycle. While a significant increase in the number of eggs retrieved was achieved, the suming treatment.
It may be concluded that despite the higher risk of number of embryos and the pregnancy rate did not differ significantly. Similarly, Rombauts et al. (52) , cancellation rate and the possible nondesirable effects of CC on the reproductive tract, CC/hMG regimens who studied the effectiveness of recombinant human FSH therapy in 40 low-response patients, found no seem to be cost-effective and should be considered in the treatment of low responders.
additional benefit from its use. It may be concluded that at higher doses, some improvement in response may be achieved, but at some High-Dose Gonadotropins (hMG or FSH or point saturation kinetics are attained, which place a hMG/FSH) Protocol limitation on the effectiveness of this form of therapy. One of the initial approaches in the treatment of low responders was to increase the dose of gonadotropin administered, starting on cycle day 1-3, with the GnRH-Agonists Protocols in Low Responders expectation that these patients would respond to the higher serum levels of gonadotropins with an increase A variety of GnRH-a protocols have been developed since the 1980s, and their use has gained widespread in the number of oocytes recruited. Unfortunately, endogenous LH levels were suppressed and premature popularity for ovarian stimulation since then. Some prospective studies showed no difference in pregnancy luteinization and ovulation continued to be a risk with this stimulation and required frequent monitoring of rates when either a long or a short protocol is used (53, 54) . However, several retrospective studies and LH (44).
In an early study, Laufer et al. (45) used a relatively large prospective studies demonstrated that the long GnRH-a protocol is superior to the short protocol in high dose of hMG in their stimulation regimen in an effort to enhance pregnancy rates. Although at least terms of follicular recruitment, oocyte recovery, fertilization rates, and number of embryos (55, 56) . This two cleaved embryos were obtained in more than 80% of the cycles, their pregnancy rate was comparable to effect has been attributed to the abolition of premature LH surges and to synchronization of follicular recruitthat described previously with a more conservative approach (46), raising doubts about the cost-effectivement as a result of pituitary desensitization. Unfortunately, prior suppression, according to the ness of the high-dose hMG treatment. In another study, Hofmann et al. (47) , who evaluated the effect of highlong protocol with GnRH-a, in low responders has been found to result in excessive dampening of the dose FSH (6 ampules/day) ovarian stimulation in lowresponder patients for IVF, reported that while there ovarian response to hormonal stimulation, so that cancellation rates, due to lack of ovarian response, are was no change in the number of oocytes retrieved, fertilized, or transferred, the cancellation rate was unacceptably high or hormonal stimulation is excessively prolonged with increased cost and duration of reduced, whereas the pregnancy rate was improved.
However, other groups have shown lower pregnancy treatment without a significant improvement in the yield of mature oocytes (5 for low responders in whom the GnRH-a was initiated in the midluteal phase, terminated by the onset of of the initial stimulatory effect of GnRH-a action on pituitary hormone levels, and thus can be employed menses, and then followed by high-dose gonadotropin therapy. A 12.5% cancellation rate was reported as a to improve the stimulatory response of low responders (58, 59 ). Muasher (5) reported a low cancellation rate result of inadequate response. However, the majority of the patients produced an adequate number of mature (5%) in 150 cycles of poor responders using a flareup GnRH-a protocol starting on cycle day 2 and four oocytes (approximately 10 oocytes per stimulation attempt), achieved three or more embryos per transfer to six ampules of FSH starting on day 3. Padilla et al. (60) , who evaluated the flare-up protocol with highresulting in an acceptable clinical pregnancy rate of 32% per transfer (65). dose FSH and hMG for IVF in poor responders in comparison to good responders, reported a significantly higher cancellation rate in the former group than Minidose GnRH-a Protocol the latter (11.3% and 1.1%, respectively). In addition, lower peak E 2 levels, decreased number of oocytes
In 1994, Scott and Navot (66) offered a novel approach to the poor responder with the introduction retrieved, and number of embryos available for transfer characterized the low-response group. Importantly, of a microdose GnRH-a flare protocol, after oral contraceptive pretreatment. They found that approxihowever, the fertilization and pregnancy rates for the patients who had responded were the same as in good mately 2% of the normal dose of GnRH-a (20 g leuprolide acetate, BID) was able to stimulate signifiresponders (60) . Also, Yang et al. (61) showed that in patients with FSH:LH ratios, either Ն 3.0, Ն 2.5, or cant endogenous gonadotropin release and to inhibit premature LH surges in 100% of cases. Compared Ն 2.0, the pregnancy rates were higher when using the short than the long protocol. An important drawback in with a luteal GnRH-a protocol, this microdose GnRHa flare protocol improved stimulation outcome in 90% using the short protocol is that patients who receive GnRH-a in this early phase will have an increase in of cases. In accordance to these results, Feldberg et al. (67) gonadotropins that also may induce enhanced ovarian androgen release, corpus luteum rescue, and a secondstudied minidose luteal phase GnRH-a [Decapeptyl (D-Trp 6 , Ferring, Malmo, Sweden)] with hMG adminary decline in oocyte quality and ongoing pregnancy rates compared with those who receive GnRH-a in istration in poor responders with elevated basal FSH levels. They found that patients who received 0.1 mg/ the midluteal phase (62). Karande et al. (63) , in a prospective study of 80 poor-response patients treated day of agonist from the midluteal phase until menstruation and then 0.05 mg/day thereafter had higher peak with the flare-up protocol, reported that while its application often will lead to an adequate ovarian response, E 2 levels, increased number of oocytes recovered, and higher number of embryos transferred compared with oocyte retrieval, and embryo transfer, the pregnancy rate remains low (6.5% per retrieval). Nevertheless, patients who were treated with higher Decapeptyl daily doses. They also noted a trend toward improved pregexperience to date shows that the short protocol has an important role in the treatment of low responders nancy rates and implantation rates and a lower spontaneous abortion rate. Surrey et al. (68) recently studied and may be used as first-line therapy.
Other protocols for low responders also have been the clinical and endocrine effects of a minidose GnRHa flare regimen administered to poor responders who developed. The ultrashort protocol, as the short protocol, takes advantage of the initial surge of gonadotropin are undergoing IVF, and found significantly improved results by the application of this regimen compared to secretion induced by the GnRH-a, which is administered for only 3 days in the early follicular phase, days a standard GnRH-a long protocol. Cycle cancellation rates were significantly decreased, and the percentage 2, 3, and 4. This protocol has proved to be advantageous compared with the long protocol in respect to of patients able to undergo embryo transfer was significantly increased with this approach regardless of the length of the treatment cycle and the amount of menotropin needed. However, premature ovulation and patient age. Peak serum E 2 levels were greater with the use of the microdose regimen, but there was no cycle cancellation are still troublesome with the ultrashort protocol compared with short and long protocols.
evidence (73) reported that, although GH did not retrieval in a group of patients with a previously poor response.
increase oocyte numbers or peak E 2 , it did significantly increase the fertilization rate per oocyte and In summary, these studies show that the use of a microdose GnRH-a protocol as part of a COH regimen therefore the yield of embryos for subsequent transfer, a finding that may be clinically important in a group for poor responders who are candidates for IVF-ET may result in significantly decreased cycle cancellaof patients like the low responders from which very few oocytes are retrieved. However, further studies tions as well as increased clinical and ongoing pregnancy rates. The mechanism by which this improved failed to demonstrate an improved clinical response following the addition of adjuvant GH therapy to outcome is achieved has not been clearly verified, but it may involve an enhanced release of early follicular ovulation induction with the use of exogenous gonadotropins. In a large, randomized, well-controlled phase FSH without concomitant increase in circulating LH or progesterone levels. study, Hughes et al. (74) failed to elicit any clinical advantage of the addition of GH to poor responders receiving GnRH-a/hMG undergoing IVF therapy. In a double-blind placebo-controlled study using a flare-
SUPPLEMENTARY FORMS OF TREATMENT TO THE OVULATION up protocol for ovarian stimulation, Suikkari et al. (75) demonstrated no improvement in cycle outcome

INDUCTION REGIMENS
with daily adjuvant human GH administration provided in doses of 4 or 12 IU.
Growth Hormone
There is a difficulty in comparing the results of these studies because of heterogeneity in patient selection, Growth hormone (GH) has been recognized as having a possible role in the regulation of ovarian follicular dosages of GH and regimens used, and the definitions of low ovarian response. However, from the data development and has been clinically investigated for its use in intensifying the ovarian response to hMG reported thus far it may be concluded that poor IVF responders do not seem to benefit from cotreatment for ovulation induction. Initial studies have shown that GH may enhance the gonadotropin effects on granuwith human GH during their ovarian stimulation. Growth hormone-releasing hormone (GHRH) also losa cells in culture, either via locally acting insulinlike growth factor-I (IGF-I) or by direct GH action, and has been studied as an adjuvant tool in ovulation induction in low-responder patients. While results reported thus, its inclusion in stimulation regimens might lead to a shorter duration of treatment, a lower total dose thus far are conflicting regarding its efficacy, Busacca et al. (76), in a recent prospective randomized trial, of required gonadotropins, and a possible increased response (70).
found that GHRH used with FSH to induce follicular development in low responders resulted in an increased Homburg et al. (71) have suggested that cotreatment with biosynthetic human GH sensitizes the human number and size of follicles, but no difference was noted in pregnancy rates between the GRF-treated and ovary to the stimulatory effect of treatment with gonadotropins. They followed their study by a randomized, control patients. double-blind, placebo-controlled trial in a group of patients with hypogonadotropic hypogonadism that Glucocorticoids reconfirmed the positive role of GH in the augmentation of ovarian response. Thus, it was assumed that Glucocorticoids have been shown to have a beneficial effect in selected patients during COH. Studies of a major application of GH supplementation might be in improving the outcome of treatment in women with patients enrolled in IVF-ET programs suggested an indirect effect of cortisol on the ovaries and an essential poor ovarian response.
role of cortisol in the maintenance of granulosa cell
In a recent study, Lindheim et al. (80) also reported the effectiveness of this form of treatment. While in cultures. The proposed mechanisms of action include a direct action of glucocorticoids on the ovaries, on their study no significant improvements were noted on the stimulation characteristics of COH as measured the gonadotropin production at the pituitary level, and by suppressing the adrenal androgens. Adjuvant glucoby days of stimulation, number of ampules of gonadotropins used, peak E 2 and progesterone, number of corticoid therapy to the treatment of low responders also has been investigated, however, with disappointretrieved oocytes compared to more standard stimulation protocols, and the pregnancy rate was significantly ing results. There seems to be no enhancement of the ovarian response or improvement in the pregnancy enhanced (30% vs. 6%). They proposed as potential mechanisms of action the production or alterations of rate. However, individual patients, such as those in a hyperandrogenemic state and patients in stress, in local ovarian growth factors and/or changes in endometrial expression. specific circumstances may benefit from glucocorticoid supplementation due to its effect on the ovaries, In summary, pretreatment with OC may represent an alternative protocol for poor responders, and may adrenals, and pituitary glands (77). be worth attempting before directing patients to oocyte donation.
Oral Contraceptives
Suppression of the pituitary-ovarian axis may also
Natural Cycle for IVF be achieved by the use of oral contraceptives (OC). Induction of a transient hypoestrogenic state by OC Stimulated cycles that result in only a few recruited follicles are similar to natural IVF cycles in that a before commencing COH treatment has been recommended for improving the prediction of the timing of single or a small cohort of dominant follicles is aspirated. Thus, in selected patients with a diminished follicular aspiration. Moreover, Gonen et al. (78) have demonstrated that pretreatment of an IVF cycle with ovarian reserve an attempt at IVF using a natural cycle may be offered with reasonable pregnancy rates. An OC may be associated with a reduction in the amount of gonadotropins required for ovarian stimulation and early report of a successful pregnancy following natural cycle IVF was in a poor-responder patient. with a higher yield of aspirated oocytes.
Scott and Navot (66) pretreated poor responders Lindheim et al. (81) recently evaluated two groups of poor responders who were treated either by a long with OC before applying their minidose GnRH-a flareup protocol and reported significantly improved outprotocol using leuprolide acetate and hMG or by applying a natural cycle. There were no differences come. Using a similar approach, Schoolcraft et al. (69) reported improved COH in poor responder IVF between the two groups regarding the number of embryos transferred and the pregnancy rates. A greater patients by applying a precycle treatment with OC followed by a microdose FSH flare-up growth hornumber of oocytes were retrieved using the stimulation protocol, but the fertilization and implantation rates mone protocol. They proposed that pretreatment of each cycle with OC possibly was a significant factor were lower in this group, suggesting that the oocyte and embryo quality might be lower in stimulated cycles in the successful clinical outcome seen, and this could be explained by the fact that by eliminating the exisof poor responders than in natural cycles. Therefore, in cases of repeated failures with standard stimulation tence of a corpus luteum from the prior cycle, the flare effect of GnRH-a was unable to rescue a preexisting protocols or those reluctant to proceed with ovum donation employing natural cycles may be considered corpus luteum and its associated premature progesterone production. Fisch et al. (79) pretreated 42 low a last resort. responders with OC for 28-42 days followed immediately by gonadotropin stimulation and compared the results with those obtained in previous stimulation POSTOOCYTE RETRIEVAL TREATMENT BLASTOCYST TRANSFER cycles of the same women with the CC/hMG regimen. Significantly higher peak E 2 levels and number of preovulatory follicles were noted in the former group.
Blastocyst transfer may prove beneficial in several groups of patients: those with repeated implantation The cancellation rate (34% vs. 75%), the number of oocytes retrieved (6.1 Ϯ 3.0 vs. 2.4 Ϯ 1.3), and the failure; those with uterine abnormalities that preclude multiple pregnancies, thus requiring more careful pregnancy rate (16.1% vs. 0%) were also better in the OC pretreated group. selection of the single embryo transferred; patients suspected of defects in oocyte quality, thus requiring embryo implantation by producing an artificial opening in the zona pellucida. In 1989, Cohen et al. (84) embryos to be assessed for a more extended period of in vitro development; patients needing embryo biopsy observed a higher implantation rate per embryo following partial zona dissection (PZD) and postulated that for genetic selection; and patients undergoing replacement of supernumerary embryos frozen at the blastothe opening made in the zona may aid the embryo in the hatching process. Since that report, many IVF cyst stage.
Animal experiments indicate a high implantation, programs have utilized assisted hatching to produce a small opening in the zona pellucida prior to embryo pregnancy, and live birthrate when following blastocyst transfer (82) . These observations indicate that transfer in an effort to increase the rate of implantation. Initial results have demonstrated that assisted hatching human IVF-ET may be enhanced dramatically, if embryos were grown under improved conditions to may be beneficial in couples of advanced maternal age, elevated basal FSH concentration, repeated failed the blastocyst stage before transfer.
Data to date on the replacement of human blasto-IVF or embryos with poor morphology due to increased zona thickness (Ն 15 m), high degree of cysts on day 5 of development in culture indicate that such embryos have a high implantation rate. For good fragmentation, and low developmental rate. Schoolcraft et al. (85) reported significantly increased pregquality eight-cells and for expanded blastocysts, implantation rates of 18% and 35%, respectively, have nancy (64 vs. 19%) and implantation rates (33 vs. 6.5%) in poor-prognosis patients receiving assisted been reported (82) . Gardner et al. (83) evaluated the implantation rates achieved by the transfer of blastohatching compared with those who did not. In 1995, Stein et al. (86) evaluated assisted hatching using the cysts on day 5 compared with embryos transferred on day 3. Implantation was significantly increased when PZD technique in 154 patients who had undergone at least three IVF treatment cycles yielding good-quality embryos were transferred on day 5, compared with those transferred on day 3 (45.5% and 21%, respecembryos but with no pregnancies initiated. The results demonstrated a significant increase in pregnancy rates tively). The ongoing pregnancy rate for embryos transferred either on day 3 or on day 5 was equivalent, only in patients aged Ͼ 38 years (23.9%) compared with control patients (nonhatched) in the same age although significantly fewer embryos were transferred on day 5, thus minimizing the risk of multiple gestagroup (7%). There was no significant decrease in pregnancy rates demonstrated in patients aged Ͻ 38 years. tion (83) .
Therefore, blastocyst culture and transfer in human Other more recent reports have shown similar results, proposing a beneficial effect of AZH in poor prognosis IVF seems to provide potential advantages: synchronization of the embryo with endometrial development, patients (87) . In contrast to these reports, others have found no leading to increased implantation rates, and selecting the most developmentally competent embryos for positive effect of AZH on IVF success rates in poor responders. In a recent prospective randomized study transfer, thereby avoiding transfer of embryos predestined to arrest. While these rationales also seem to be using the PZD technique, Hellebaut et al. (88) found no increase in pregnancy or implantation rates by the favored in the treatment of low responders, no study thus far has examined the value of blastocyst culture application of this procedure. In another study, Tucker et al. (89) found the clinical pregnancy rates to be and transfer in this group of patients. Since the main problem of blastocyst transfer is the suboptimal culture significantly higher following AZH in patients aged Ͼ 35 years (45.2%) compared with control patients conditions, implying that only a fraction of the embryos will reach the blastocyst stage, a great (16.7%). However, the ongoing pregnancy and implantation rates were not significantly different among the dilemma exists whether to apply this form of treatment to low responders, who a priori have a reduced number two groups (89) . Also, in a recent prospective, randomized, double-blind study, Lanzendorf et al. (90) of embryos. Improved culture conditions leading to higher blastulation rates may provide the necessary reported no significant impact of AZH in their population studied. tools for applying blastocyst culture and transfer in low responders.
Differences in methodology, study design, patient and embryo selection criteria, and low number of subjects may explain the diversity in the reported results
ASSISTED HATCHING
and make the interpretation of the effects of AZH on IVF success rates difficult. It seems, however, that Assisted zona hatching (AZH) has been applied in ART in order to promote hatching and subsequent some groups of elderly poor-prognosis patients may benefit from its application. In the near future, new and significant progress has been achieved with the introduction of the coculture systems. (93) reported Diminished number of retrieved oocytes has been associated with lower fertilization rates and IVF outthat the combination of coculture and selective assisted hatching provided a 45% ongoing pregnancy rate with come. In addition, others reported that fertilization failure was present in about 16% of the IVF cycles a 23% implantation rate and concluded that certain patients' subgroups may benefit the most from coand more frequent when fewer than three eggs were retrieved. In low responders, usually a small number of culture. These include patients who have previously failed IVF attempts, or have endocrine imbalances oocytes are retrieved after COH. Whether conventional IVF or intracytoplasmic sperm injection (ICSI) should such as polycystic ovarian syndrome and elevated day 3 serum FSH levels. The benefit from applying coculbe applied to this group in order to increase the fertilization rate remains still an open question.
ture techniques in low responders currently is insufficiently investigated and its value unknown. In a prospective study of 96 low-responder patients, Moreno et al. (91) reported no differences in the fertilization rate, number of embryos transferred, and pregnancy and implantation rates, after ICSI or Cytoplasm and Nuclear Transfer in Human conventional IVF. They concluded that in cases of Oocytes non-male infertility the technique of fertilization is not related to the reproductive outcome of low Waning oocyte quality seems to be the principal factor responsible for the age-related decline in female responders and that the routine use of ICSI is not indicated. Conversely, other recent reports have fertility. With increasing age, oocyte quality becomes impaired, leading to poor embryo quality and conseshown that ICSI can be used successfully on nonmale factor couples to provide comparable or even quently low implantation rates and high pregnancy wastage. This deterioration in oocyte quality seems to higher fertilization rates and superior quality of embryos than those obtained after standard IVF (92).
result from cytoplasmic and nuclear alterations (4) . The role of the ooplasm in mammalian oocyte matuDue to the variability of the data and until further information is provided, it may be concluded that ration and activation has been well documented but is far from complete understanding (94) . An equally in low responders without male infertility, ICSI should be the method of choice in a second attempt critical importance of ooplasmic factors is postulated for the continued development of the zygote, particuwhen previous fertilization failure with conventional IVF has occurred. larly during early cleavage, when transcription of the embryonic genome is minimal. Some nongenetic anomalies that originate in the ooplasm rather than in the embryonic genome may and often do interfere OTHER POTENTIAL FORMS OF TREATMENT with normal development and as a consequence may threaten the viability of the embryo concerned. Keefe et al. (95) proposed that oocytes from older women Coculture in Assisted Reproduction were more likely to contain deleted mitochondrial DNA (mtDNA) than oocytes from younger women, The marginal improvement in implantation rates achieved over the last years has enhanced researchers' and that these alterations could have adverse cellular effects by disrupting the normal electron and energy efforts in evaluating other methods by which embryo development may be improved. As a result, a search transport chain, leading to high levels of intracellular reactive oxygen species and cellular dysfunction. for more optimal in vitro conditions was initiated, Transfer of ooplasm from a donor oocyte obtained response patients, particularly of older age, thus enhancing their implantation and pregnancy rates. from a young patient may achieve restoration of normal developmental potential to eggs with ooplasm defiHowever, these treatments currently are experimental in nature and their real efficacy is unclear. In addition, ciencies. Patients who may benefit from this form of treatment are those that produce oocytes with an they raise a number of ethical issues, like the introduction of a completely new set of mtDNA from the donor assumed normal nuclear genome but an ooplasm that is abnormal or deficient due to maternally mediated to the recipient oocyte, which may lead to the creation of a three-parental individual. As a result of these factors. Thus, the criteria used in selection of patients are crucially important, since ooplasm transfer clearly unresolved issues and until further studies indicate the best approaches for their application, the demand for could not be expected to cure problems that are either causally unrelated to the constitution of the ooplasm these new procedures may be overshadowed. of the mature egg or have become irreversible by the time the procedure is carried out. Cohen et al. (94) In Vitro Maturation of Immature Human recently reported ooplasm transfer in seven couples Oocytes (eight cycles) with multiple implantation failures by using either electrofusion of an ooplasmic donor fragHuman oocyte maturation is considered as the reinitiation and completion of the first meiotic division from ment into each patient's egg (three cycles) or direct injection of ooplasm from a donor egg into each patient the germinal vesicle stage (prophase I) to metaphase II and the accompanying cytoplasmic maturation for (five cycles). Normal fertilization and improvement in embryo morphology were significantly higher by fertilization and early embryonic development. In vitro maturation (IVM) of immature oocytes and the applying the latter method, by which three pregnancies were achieved, leading to a normal pregnancy and achievement of pregnancy potentially can be a major advance in ART as it obviates the need for the hyperstidelivery; a miscarriage; whereas a third pregnancy is still ongoing. Amniocentesis performed in the two mulation of women, which is potentially hazardous and costly. The first pregnancy in humans from IVM pregnancies confirmed the nuclear characteristics matching those of the parents, thus excluding the possioocytes was reported by Cha et al. (97) , who aspirated oocytes in various stages of maturity from surgically bility of transfer of nuclear material from the donor during the ooplasmic transfer. In addition, sensitive removed ovaries, and cultured them for 32-48 h in two-culture systems, one containing fetal cord serum assays performed did not detect possible donor mtDNA in the fetus.
and another containing 50% mature follicular fluid. They reported 36% and 50% maturity rates and 32% It also has been well established that in humans the number of chromosome abnormalities, especially and 81% fertilization rates in the two culture systems, respectively. A significant improvement to the applicaaneuploidy, increases with age, affecting embryo development. Additionally, unfertilized oocytes from tion of this technique was later achieved by Trounson et al. (98) , who reported that a reasonable oocyte recovin vitro fertilization cycles have shown a high percentage of chromosomal perturbations. In a study, where ery rate can be achieved by transvaginal ultrasoundguided follicle aspiration in small growing follicles (Ն 60 oocytes from 28 women between 27 and 41 years of age were analyzed, correlation was found between 3 mm diameter). However, their pregnancy and live birthrate was very low, reaching only 2% (98). maternal age and aneuploidy in oocytes and between morphology and genetic balance in preimplantation
The nature of the culture medium seems to be the key factor contributing to the success of an IVM proembryos (96) .
Nuclear transplantation from an older oocyte to a gram, and thus many factors are being evaluated in an effort to increase the efficacy of this method. Currently, donor-enucleated cytoplasm also has been proposed in order to overcome any effects induced by age-related the present situation is that immature oocytes can be recovered efficiently from small follicles by transvagicytoplasmic alterations, and an initial report of germinal vesicle transfer has been described as successfully nal follicular aspiration. The oocytes show nuclear maturation changes consistent with ultrastructural and proceeding to extrusion of the first polar body. However, fertilization was not proved and progression to cytogenetic observations of oocytes matured in vivo and they fertilize and cleave as expected for in vivo creation of a human embryo and to the establishment of pregnancy was not reported (96) . matured oocytes recovered from IVF patients in whom ovulation was stimulated. However, in oocytes Cytoplasm and nuclear transfer in human oocytes may lead to an improvement of oocyte quality in lowmatured in vitro there still is a major problem of embry- onic developmental competence, particularly cleavage quality (4). Evidence exists that an adequate estrogen intrafollicular milieu is important in the oocyte's acquiand development beyond the four-cell stage (99).
It has been well known that after the age of 35 years, sition of developmental competence and cytoplasmic maturation including activation, synthesis of the male the endocrine system in women shows significant changes, with a rapid rise in serum FSH levels, and pronucleus growth factor, and preimplantation development (100). Thus, it may be assumed that the low likely it can be expected that other regulatory systems change as well. Because of this change in the endocrine intrafollicular estrogen levels produced by poor responders may be associated with the low response environment, follicular growth and oocyte maturation may be affected, and in turn this may affect oocyte to COH, and may affect at least in part an oocyte's
